Allocation of registration charges: contractual clause overriding statutory presumption allowed as deduction against capital gain after unrebutted doc...
Expenditure tied to investments yielding exempt income restricted to attributable costs; broader disallowance disallowed and adjustments to WDV and mi...
Admissibility of Investigative Statements invalidated reliance on coerced emails and valuation redetermination, resulting in set aside of penalties an...
Classification of printed technical documents: specific Chapter 49.01 entry prevails, enabling claimed customs exemptions for imported manuals and rep...
Deduction for capital expenditure on scientific research under...
Pre-commencement R&D deduction denied where business had not commenced; deeming benefit requires tangible start of manufacture or commercial exploitation.
Contents
Summary
Note
Bookmark
Share
✓ Copied successfully !
Print
Print Options
For full text, please login
Login to TaxTMI
Verification Pending
The Email Id has not been verified. Click on the link we have sent on
Deduction for capital expenditure on scientific research under section 35(1)(iv) is subject to the deeming rule only where the taxpayer has in fact commenced the business that will exploit the R&D; the deeming benefit for expenditure in the three years prior hinges on an ascertainable start of manufacture or commercial exploitation. The Tribunal held that absence of purchases, sales, closing stock, and only capital work in progress and unbilled dossier revenue showed no commencement; it allowed the Revenue's appeal, reversed the CIT(A) and upheld the AO's disallowance for AY 2018 19.
Deduction for capital expenditure on scientific research under section 35(1)(iv) is subject to the deeming rule only where the taxpayer has in fact commenced the business that will exploit the R&D; the deeming benefit for expenditure in the three years prior hinges on an ascertainable start of manufacture or commercial exploitation. The Tribunal held that absence of purchases, sales, closing stock, and only capital work in progress and unbilled dossier revenue showed no commencement; it allowed the Revenue's appeal, reversed the CIT(A) and upheld the AO's disallowance for AY 2018 19.
Note: It is a system-generated summary and is for quick reference only.